08:00 , Feb 7, 2005 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Cellectricon AB Stockholm, Sweden Technology: Dynaflow ion channel analysis, Cellaxes target validation and screening technology, Axoporator single cell electroporation technology Disease focus: NA Clinical status: NA Founded: 2000 by Daniel Chiu, Owe Orwar and Jacob Lindberg University collaborators: Chalmers University of...